Meet Inspiring Speakers and Experts at our 3000+ Global Events with over 1000+ Conferences, 1000+ Symposiums and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series : World’s leading Event Organizer

Conference Series Conferences gaining more Readers and Visitors

Conference Series Web Metrics at a Glance

  • 3000+ Global Events
  • 100 Million+ Visitors
  • 75000+ Unique visitors per conference
  • 100000+ Page views for every individual conference

Unique Opportunity! Online visibility to the Speakers and Experts

Recommended Global Reproductive Medicine & Women Healthcare Webinars & Conferences

Asia Pacific & Middle East



About Conference

Polycystic ovary syndrome is the most common hormonal abnormality in reproductive-aged women, affecting up to 10% of them. It is distinguished by an excess of the androgen testosteroneirregular menstruation, and enlarged ovaries containing multiple small follicles (polycystic ovaries).

PCOS needs to be made more widely known because more than half of the 10,000,000 people who have it are unaware of it. Awareness educates the public on the importance of seeking medical attention for symptoms such as irregular periods and pelvic pain.

The “ 8th World Congress on Polycystic Ovarian Syndrome & Infertility ” is part of the Conference Series, going to be held on 

November 16-17, 2023 Amsterdam, Netherlands​ aims to bring together prominent researchers, academic scientists, and research scholars to exchange and discuss all facets of obstetrics and gynaecology and their personal experiences. Additionally, it serves as a forum for knowledge domain sharing and discussion for researchers, practitioners, and educators.

We cordially invite you to participate as a speaker, delegate, or exhibitor at the upcoming conference, “ 8th World Congress on Polycystic Ovarian Syndrome & Infertility ”  on behalf of the organizing committee.


Sessions & Tracks


Track 1- Polycystic Ovary Syndrome (PCOS)

Polycystic ovary syndrome (PCOS) is a heterogeneous endocrine syndrome with variable prevalence, affecting about one in every 17 women worldwide Anovulation , clinical and biochemical evidence of hyper androgenise, and the morphology of polycystic ovaries must all be present for the diagnosis of polycystic ovary syndrome to be made. Metabolic syndromes, hypertension, and cardiovascular diseases appear to be more common in women with PCOS.

Track 2- Fertility and Infertility – Women

Fertility is the capacity to produce posterity and conceive. Human fertility depends upon various elements. Ovulation is a woman's most fertile period. Within the 11th to 21st day of a woman's cycle, ovulation takes place. Both men and women can experience infertility, and both are affected almost equally. Both male and female infertility can be treated with ARTs.

Track 3- Women’s Health Related Issues

Women's health has been a long concern but nowadays it has reached an extreme point of concern. Normally, men and women face similar health issues; the only distinction is that women's health needs special consideration. Pregnancy and childbirth are biological processes that pose health risks and are the leading cause of death for young women in developing nations between the ages of 15 and 19. HIV/AIDS is the leading cause of death in women of reproductive age and is caused by biological factors, a lack of knowledge among women about HIV, and unsafe sex. Unwanted pregnancies, unsafe abortions, STDs, etc. are caused by the lack of contraception.

Track 4- Gynaecology

Gynaecology and Obstetrics is the medical specialty that includes the two subspecialties of obstetrics and gynaecology that is covering the health of the female reproductive systems (i.e, vagina) and ovaries. Gynaecology is a subspecialty of medicine that deals with providing health care to women, particularly the analysis and treatment of conditions affecting the female reproductive system. It also studies diseases that affect female reproductive surgery, including problems with reproductive hormones.

Track 5- Gynaecological Endocrine Disorders in PCOS

Polycystic ovary syndrome (PCOS) is a typical reason of ovulatory days function. This disorder involves an ovulation days function and androgen excess of unclear ethology. The risk of endometrial hyperplasia and, eventually, endometrial cancer rises as estragon levels rise. Regularly elevated androgen levels increase the risk of metabolic syndrome and lead to hirsutism. Insulin resistance can lead to hyperinsulinemia, which can increase the production of androgens in the ovaries. the possibility of cardiovascular diseases, such as hypertension and high cholesterol. Ovulatory dysfunction is frequently caused by polycystic ovary syndrome (PCOS). Anovulation days function and androgen excess with unknown ethology are symptoms of this disorder. The risk of endometrial hyperplasia and, eventually, endometrial cancer rises as estragon levels rise. Regular androgen elevation increases the risk of metabolic syndrome and results in hirsutism.

Track 6- Pregnancy Hypertension

Hypertension is the major medical problem comes upon during pregnancy, complicating up to 15% of pregnancies. There are four different types of hypertensive disorders that can occur during pregnancy: chronic hypertension, gestational hypertension, preeclampsia, and eclampsia. Pregnancy complications involving hypertension are among the most serious and have a big impact on maternal, perinatal, and infant morbidity and mortality. The main goal of treatment is to protect the mother from serious cerebrovascular and cardiovascular events without compromising the health of the fetus.

Track 7- Reproductive Endocrinology and infertility

Reproductive Endocrinology and Infertility is belongs to the Department of Obstetrics and Gynaecology. Human reproduction, including male and female infertility, assisted reproductive technologies, is the subject of the research. Among them are hormone-related problems, uterine fibroids, polycystic ovary syndrome, endometriosis, reproductive surgery, and endometriosis. Another type of assisted reproductive technology used to treat infertility is in vitro fertilization.

Track 8- Complications during pregnancy

Women face lots of health problems during pregnancy. These problems can involve the mother's health, the fetus health, or both. Even women who were in good health prior to becoming pregnant may experience difficulties. These challenges could lead to pregnancy complications.

The following are some typical pregnancy complications.

Track 9- Immunological Approaches of fertility

Immune infertility has become a severe health issue involving 2 in 10 women under normal conditions; Moreover, it has become quite common to see a woman with polycystic ovarian syndrome. The composite fluid known as semen, which contains sperm, cellular vesicles, and other cell components, may be the cause of the female genital tract becoming sensitized. Infertility is also linked to iso-immunization. Numerous elements of the regenerative system do not correspond to those many of our immunogenic efforts found in other body systems. The main benefit of using an immunological approach to fertility is the potential for women who experience infertility infrequently to receive antifertility treatments from trained professionals.

Track 10- PCOS Advanced Research

Effective study about the PCOS gives that it is caused by abnormal functioning of hormones and by the metabolic endocrinological disorder. More research is being done to determine the exact cause of the disorder and how to partially stop future PCOS-related actions from getting worse. Recent studies have focused on a plant substance called resveratrol, which is produced through plant synthesis. Most plants contain a type of phenol called phytoalexin, which is derived from plant tissues in response to invading fungi and stress. Resveratrol has an antioxidant property and has anti-inflammatory properties, which it uses to reduce coronary heart disease and effectively fight cancer. Women with PCOS are administered a resveratrol drug into their systemic circulation, which may work effectively against hormonal imbalances. After three months of treatment, the patient's blood can be drawn for analysis to determine the levels of testosterone and other androgen hormones that indicate the emergence or manifestation of the syndrome. This describes how the tool has changed. Including natural foods in your diet, such as almonds, milk, and vegetables, can help to increase fertility and promote healthy hormonal function.

Track 11- Research in Clinical Obstetrics and Gynaecology

Obstetrics is generally known as the branch that which deals with the study of pregnancy, childbirth, and the postpartum period. Based on the ensuing modifications to surgical techniques, it is combined with the gynaecological division, and as a surgical specialty, it is commonly known as obstetrics and gynaecology. Obstetrics is linked to gynaecological conditions like polycystic ovarian syndrome (PCOS), which affects pregnant women in a variety of ways. PCOS's consequences are most severe for reproductive women. Preeclampsia and gestational diabetes can affect women with PCOS. Maternal bleeding and sepsis are the primary causes of maternal mortality because of this. There is no distinction between symptoms and pregnancy complications or discomfort.

Track 12- Diagnosis and Treatment of Polycystic Ovary Syndrome

Polycystic ovary syndrome is the common endocrinopathy among reproductive-aged females in all over the world, affecting approximately 6% of female patients. It is hypothesized that insulin resistance is a key factor in the pathophysiology of the disease, which can range from being asymptomatic to having multiple gynaecologic, dermatologic, or metabolic manifestations. The pathophysiology of the disease is complex, and there is no single defect from which it is known to result. The Rotterdam criteria for diagnosis, which call for the presence of two of the following three findings—hyperandrogenism , ovulatory dysfunction, and polycystic ovaries—plus the exclusion of other diagnoses that could lead to ovulatory dysfunction, were recommended by the Endocrine Society.

Track 13- PCOS & Stem Cell treatment

Stem cells are homogeneous cells which are capable of self-renewal (reproducing themselves) and distinguishing into different types of cells. Self-renewal and potency, which enable stem cells to differentiate into any type of cell, are the two key characteristics of stem cells. As of late in 2004, two studies showed that ovaries do contain stem cells that develop into oocytes in adults and can be cultured in vitro to produce children. Another study provided novel confirmation of the stem cell-mediated endometrial recovery in women who underwent bone marrow transplants. This discovery may be used to treat uterine disorders and has the potential to be used in such treatments. It also lends support to a novel theory explaining the origin of endometriosis, a condition in which the endometrium's own cells proliferate outside of it.

Track 14- Fertility Surgery and IVF Treatment

In vitro fertilization is a type of assisted reproductive technology which is used in infertility treatment or genetic problems and assist with the conception of a child. IVF involves the external fertilization of an egg by sperm in a liquid medium in a specialized laboratory. The zygote undergoes embryo culture for 2–6 days, after which the expert re-implants the embryos into the woman's uterus. This procedure aims to start a fruitful pregnancy.

Track 15- Effects of Drugs on Pregnancy

Pregnancy is a special physiological condition where treatment of drug is an important concern as the physiology of pregnancy affects the pharmacokinetics of treatment used some medications can reach the fetus and harms them. Since some pregnant women may have chronic pathological conditions like asthma, epilepsy, and hypertension that call for ongoing or intermittent treatment, it is impossible to completely avoid treatment during pregnancy. During pregnancy, new medical conditions can arise, and pre-existing ones can get worse, necessitating drug therapy. This presents a significant challenge for women who are pregnant or breastfeeding who need to take prescription, over the counter, or herbal medications.

Track 16- Epidemiology and Pathophysiology


Epidemiology is the study and analysis of the distribution and factors of health and disease conditions in defined populations. By identifying risk factors for disease and areas that should be targeted for preventive healthcare, it forms the foundation of public health, influences policy choices, and promotes evidence-based practice. Procedures that are used in clinical research, public health studies, and, to a lesser extent, basic biological science research have all been developed with help from epidemiology.


Pathophysiology is a part of pathology with physiology. It is a deranged function in an individual or an organ due to a disease. While physiology is the natural order that describes how processes operate inside an organism, pathology depicts conditions that are typically seen during an infection state. Pathophysiology seeks to explain the beneficial changes that are occurring inside a person because of an illness or pathologic state, whereas pathology clarifies the undesirable condition. Pathophysiology can also refer to the functional changes brought on by injury. The beneficial changes that come along with a particular illness is another definition.

Track 17- Current trends in the treatment of PCOS System

Metabolic syndrome is most common in patients with polycystic ovary syndrome when it is compared with the overall population, and patients with polycystic ovary syndrome are four times more likely than the general population to develop type 2 diabetes mellitus.

Based on the patient's symptoms and desire to become pregnant, PCOS treatment is tailored to each individual patient. Weight loss is advised for patients who are overweight for them. The first-line treatment options for infertility include clomiphene and letrozole. The first-line treatment for metabolic manifestations like hyperglycaemia is metformin. The best treatment for irregular menses and dermatologic manifestations is hormonal contraception.

Market Analysis

Importance & Scope:

PCOS 2023 deals with Polycystic and Ovarian Syndrome knowledge and characteristics, Screening, Detecting and Diagnosing PCOS, Fertility issues, Treatment, prevention, and medicine. The correct reason for PCOS is obscure. For the most part, it is a hormonal issue normal among ladies of regenerative age. Ladies with PCOS may have inconsistent or drawn-out menstrual periods or overabundance male hormone (androgen) levels. Awareness about the risks, symptoms and treatment is very important. Introduction of new techniques in the field of medicine as well as diagnosis is going on worldwide. PCOS 2023 give a stage to sharing of data about the PCOS treatment methods and recently created strategies for the same and in addition give stage about the on-going examines on it. This occasion incorporates incite keynote introductions, oral talks, blurb introductions and displays.

Major PCOS Associations around the Globe

  • Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society
  • Endocrine Society (USA)      
  • American Dietetic Association
  • American Society Reproductive Medicine
  • American Association of Clinical Endocrinologists
  • The European Society of Human Reproduction and Embryology
  • Australian Breastfeeding Association
  • Polycystic Ovary Syndrome Association of Australia
  • The Association of UK Dietitians
  • Canadian Fertility and Andragogy Society Polycystic Ovarian Syndrome Association
  • Association for Fertility and Reproductive Health, Nigeria

     Top Societies of PCOS in the World

  • Androgen Excess and Polycystic Ovary Syndrome Society 
  • American diabetes association
  • Endocrine society of Australia

    Top Universities of PCOS in World

      Top Universities in Asia

      Companies associated with PCOS in Global


Statistics which show Market growth in importance of research of PCOS

PCOS is the commonest cause of an ovulatory infertility in women. Women may also suffer from cancer of the womb, obesity, cardiovascular disease, diabetes, and hirsutism. It affects 6-20% of women in the population and the current expected annual costs of diagnosing and treating infertility secondary to PCOS in the UK range from £15million to £20 million whereas the health economic effect of PCOS in the USA effects 10-20% and has been estimated as ranging from $93 million to $1.77 billion. Although important progress has been made in our understanding of PCOS, there are still challenges in unravelling its difficulty. The analysis of PCOS is based on a combination of clinical, ultrasound and biochemical features, none of which on its own is diagnostic single unifying mechanism has yet to be found which explains PCOS, and accurate prediction of response to treatment for obesity, infertility.

 Worldwide Data evaluations that the global PCOS therapeutics market was valued at $656m in 2010 and is expected to grow at a static Compound Annual Growth Rate (CAGR) of 2.6% over the next eight years, to reach $804m by 2018. Annualized seven key markets (US, France, Germany, Italy, Spain, UK and Japan) Polycystic Ovarian Syndrome Therapeutics market revenues data from 2005 to 2009, forecast for eight years to 2018.according to PCOS Therapeutics market revenue, the market size from 2005-2010 in Italy is 33, USA is 26, Spain is 35,in France 28,whereas in Germany is 31,whereas in UK is37  whereas from 202-2018 in Italy is 34,in us is 27,spain is36, in France is 29,in Germany is 32, whereas in UK is  38. The Polycystic Ovarian Syndrome Market Will Start Growing From 2013 Due to the Increase in Disease Prevalence and Prescription Rates and Will Rise to $702m in 2019. The global market for PCOS drugs is on an upward swing given the increasing number of cases of patients inflicted with the disease. The global polycystic ovary syndrome drugs market revenue is estimated to reach US$ 1,154.8 MN by 2024, expanding at a CAGR of 4.6% during the forecast period (2016–2024).

About Us

We are a group of publications including iMedPub LTD and Conference Series LLC LTD. We Organize 3000+ Conferences across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

We are an organization that amalgamates Open Access Publications and International science events for the benefit of the global scientific community. The organization was established in the year 2007 with the sole aim of providing a platform for "Open Access" to the research information pertaining to diversified fields of science and technology. We publish scholarly journals that can be easily accessed online without paying any subscription charges. Our organization plays an instrumental role in expanding the reach of research data in the real time, which in turn helps in furthering the research. Research Scholars, Students, Libraries, Educational Institutions, Research centres and industries are the main stakeholders that are benefitted from open access to research data. We also organize 3000+ International conferences across the globe, where knowledge transfer takes place through debates, round table discussions, poster presentations, workshops, symposia and exhibitions.

Past Conference Report

The 6th International World Congress on Polycystic Ovarian Syndrome & Infertility of the Conference Series LLC Ltd was held during July 22-23, 2022, London, UK based on the theme “Revolutionizing the Future Strategies for Women Health Research”. Conference series LLC Ltd would like to convey a warm gratitude to all the Honorable guests of PCOS Congress 2022. Conference Series LLC LTD offers its heartfelt appreciation to esteemed organizations, obliged to the Organizing Committee Members, adepts of field, various outside experts, company representatives and other eminent personalities who supported the conference by facilitating the discussion forums. We also took privilege to felicitate the Organizing Committee Members, Editorial Board Members and Media Partners who supported this event.

To Collaborate Scientific Professionals around the World

Conference Date November 16-17, 2023

For Sponsors & Exhibitors

Speaker Opportunity

Past Conference Report

Supported By

All accepted abstracts will be published in respective Conference Series International Journals.

Abstracts will be provided with Digital Object Identifier by